Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY).
Gian Paolo FadiniRaffaella BuzzettiAntonio NicolucciMonica LarosaMaria Chiara RossiDomenico Cucinottanull nullPublished in: Acta diabetologica (2022)
Initiating Gla-300 or Deg-100 was associated with similar improvements in glycemic control, no weight gain and low hypoglycemia rates, without severe episodes during 6 months of treatment.